Alyftrek 4 mg/ 20 mg/ 50 mg

Alyftrek 4 mg/ 20 mg/ 50 mg is a medicine authorised by Swissmedic under authorisation number 69398. The authorisation holder is Vertex Pharmaceuticals (CH) GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 15 October 2025 and the authorisation is limited until 14 October 2030. ATC code R07AX33 places the medicine in the group Other respiratory system products.

Dispensing category A
Authorisation number 69398
ATC R07AX33
Synthetic medicines

Authorisation data
Authorisation number	69398
Name	Alyftrek 4 mg/ 20 mg/ 50 mg
Full name	Alyftrek 4 mg/ 20 mg/ 50 mg, Filmtabletten
Authorisation holder	Vertex Pharmaceuticals (CH) GmbH
Medicinal product code	Synthetic medicines
Dispensing category	A · Prescription, not repeatable
ATC code	R07AX33
First authorisation	15 October 2025
Authorisation validity	14 October 2030

Strengths
No.	Name	Dispensing category	Authorisation date
1	Alyftrek 4 mg/ 20 mg/ 50 mg, Filmtabletten	A	15 October 2025
2	Alyftrek 10 mg/ 50 mg/ 125 mg, Filmtabletten	A	15 October 2025

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	84	Tablette(n)	R07AX33	03.99.0.	A
2	56	Tablette(n)	R07AX33	03.99.0.	A

Scroll the table sideways

Other medicines from this authorisation holder

Casgevy 4-13 x 10e6 cells/mlAuthorisation number 68978 · ATC B06AX05A Kalydeco 150 mgAuthorisation number 62686 · ATC R07AX02A Kalydeco 50 mgAuthorisation number 66169 · ATC R07AX02A Orkambi 100 mg lumacaftor / 125 mg ivacaftorAuthorisation number 67395 · ATC R07AX30A Orkambi 200 mg / 125 mgAuthorisation number 65981 · ATC R07AX30A Symdeko 100 mg / 150 mg und 150 mgAuthorisation number 66742 · ATC R07AX31A Trikafta 100 mg / 50 mg / 75 mgAuthorisation number 67773 · ATC R07AX32A Trikafta 100 mg / 50 mg / 75 mgAuthorisation number 69212 · ATC R07AX32A

Frequently asked questions

Is Alyftrek 4 mg/ 20 mg/ 50 mg authorised in Switzerland?

Yes. Alyftrek 4 mg/ 20 mg/ 50 mg is authorised by Swissmedic under authorisation number 69398, data as of 01 September 2026. The authorisation is limited until 14 October 2030.

Which dispensing category does Alyftrek 4 mg/ 20 mg/ 50 mg have?

Alyftrek 4 mg/ 20 mg/ 50 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Alyftrek 4 mg/ 20 mg/ 50 mg?

The authorisation holder is Vertex Pharmaceuticals (CH) GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.